Acorda Therapeutics, Inc. Financial Ratios — ACORQ Stock

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-27.93	-3.56	8.48	32.8	2.8	2.11	1.02	-2.82	-17.51	2.7	-26	-13.91	-19.11	-15.49	-100.32
Return on Capital (%)	- -	- -	-8.14	- -	-7.32	-28.87	25.82	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	18.13	- -	4.14	4.51	2.97	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	79.77	81.06	77.22	81.15	80.19	79.92	81.14	79.19	80.97	79.29	81.89	78.09	68.4	74.42	87.01
EBITDA Margin (%)	-143.57	-2.34	13.58	9.9	11.11	13.46	12.16	-1.12	21.77	22.27	-44.92	-29.81	-33.58	-7.78	7.14
Operating Margin (%)	-148.62	-4.41	12	8.37	9.03	11.35	9.11	-5.27	17.82	19.83	-62.89	-56.81	-59.89	-35.45	-19.78
Incremental Operating Margin (%)	- -	- -	42.95	-69.62	15.56	23.39	-0.76	- -	192.52	9.72	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-6.16	10.96	7.94	8.58	6.98	3.93	-8.13	-42.82	4.33	-142.53	-70.39	-84.51	-29.73	-251.65
Profit Margin (%)	-153.53	-6.16	10.47	50.67	4.89	4.4	2.24	-6.66	-37.8	7.14	-141.87	-65.11	-80.54	-55.59	-214.95
Net Income to Common Margin (%)	-153.53	-6.16	10.47	50.67	4.89	4.4	2.24	-6.66	-37.8	7.14	-141.87	-65.11	-80.54	-55.59	-214.95
Effective Tax Rate (%)	- -	- -	4.41	- -	43.04	36.91	42.91	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	8	8	6	5	4	291	293	331	335	344	250	260	191	173	191
ST Debt	- -	1	1	1	1	1	1	7	1	1	8	77	8	2	188
LT Debt	8	7	5	4	3	290	292	324	334	343	241	183	183	171	3
Total Debt/EBITDA	-0.1	-1.72	0.16	0.18	0.12	5.38	4.89	-57.08	2.62	3.27	-2.89	-5.7	-4.41	-18.74	22.72
Net Debt/EBITDA	0.5	6.01	-1.3	-1.21	-1.17	2.01	2.33	-29.74	0.22	0.48	-1.81	-3.58	-3.07	-14.03	18.59
Total Debt/EBIT	-0.1	-0.92	0.18	0.21	0.14	6.38	6.52	-12.09	3.2	3.68	-2.06	-2.99	-2.47	-4.11	-8.21
Net Debt/EBIT	0.49	3.19	-1.47	-1.43	-1.44	2.39	3.11	-6.3	0.27	0.54	-1.3	-1.88	-1.72	-3.08	-6.71
EBITDA to Interest Expense	-17.78	-1.14	11.11	16.1	17.22	5.82	3.87	-0.35	6.86	4.86	-3.95	-1.49	-1.44	-0.31	0.27
EBITDA-CapEx/Interest Expense	-18.33	-3.55	9.49	8.88	10.46	-46.28	3.41	-16.9	6.09	3.29	-8.09	-1.64	-1.45	-0.31	0.26
EBIT to Interest Expense	-18.41	-2.15	9.82	13.62	13.99	4.91	2.9	-1.66	5.62	4.33	-5.53	-2.84	-2.57	-1.39	-0.74
Interest Expense	4	4	4	2	2	9	15	17	19	22	22	31	30	30	32
Common Equity/Total Assets	-134.06	-128.63	-107.89	-45.01	-39.21	-20.69	-18.83	-18.17	-37.99	-30.3	-83.38	-121.13	-191.09	-236.67	-1,095.72
Long-Term Debt/Equity (%)	5.64	4.35	2.55	1.1	0.73	53.66	48.34	48.78	64.32	56.07	77.62	77.06	120.92	183.05	- -
Long-Term Debt/Capital (%)	-1.84	-1.52	-1.3	-1.7	-1.38	410.26	349.61	371.91	-278.86	-685.75	-57.83	-36.21	-26.9	-22.45	-0.32
Long-Term Debt/Total Assets (%)	2.43	1.92	1.38	0.75	0.53	27.22	26.23	24.14	27.92	26.4	30.17	28.98	40.12	43.32	2.92
Total Debt/Equity (%)	5.64	5.1	3.11	1.4	0.99	53.87	48.54	49.84	64.45	56.17	80.31	109.24	126.34	184.7	-120.85
Total Debt/Capital (%)	-1.84	-1.79	-1.58	-2.16	-1.87	411.88	351.01	379.96	-279.4	-686.98	-59.83	-51.33	-28.1	-22.65	-19.12
Total Debt/Total Assets (%)	2.43	2.26	1.68	0.95	0.72	27.32	26.34	24.66	27.97	26.45	31.21	41.09	41.92	43.71	175.9
Net Debt to Equity	-28.81	-17.8	-25.14	-9.45	-9.92	20.15	23.13	25.97	5.39	8.2	50.44	68.68	88.02	138.32	-98.87
Net Debt/Capital (%)	8.46	5.76	11.19	12.54	15.5	-97.62	-199.8	-241.58	-6.57	-14.61	-32.71	-28.29	-18.35	-16.17	-15.19
EBITDA	-78	-4	40	30	37	54	60	-6	128	105	-86	-46	-43	-9	8
EBITDA-CapEx	-81	-14	34	17	23	-430	53	-279	114	71	-177	-50	-44	-9	8
Operating Income (Loss)	-81	-8	35	26	30	46	45	-27	105	93	-121	-87	-77	-42	-23

Liquidity (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	3.73	2.55	3.39	2.36	2.83	2.69	3.9	1.07	2.13	3.18	1.46	0.52	0.84	0.99	0.13
Current Ratio	4.02	3.3	4.13	3.37	3.8	3.42	4.98	1.84	3.07	3.77	2.33	1.61	1.89	2.16	0.33
Quick Ratio	3.81	2.78	3.65	2.63	3.15	2.97	4.25	1.43	2.7	3.34	1.71	0.67	1.16	1.35	0.21
CFO/Avg Current Liab	0.61	-0.23	0.73	0.56	0.4	0.71	0.38	0.25	0.67	1.06	-1.13	-0.55	-0.43	-0.45	-0.11
Common Equity/Total Assets	-134.06	-128.63	-107.89	-45.01	-39.21	-20.69	-18.83	-18.17	-37.99	-30.3	-83.38	-121.13	-191.09	-236.67	-1,095.72
Long-Term Debt/Equity (%)	5.64	4.35	2.55	1.1	0.73	53.66	48.34	48.78	64.32	56.07	77.62	77.06	120.92	183.05	- -
Long-Term Debt/Capital (%)	-1.84	-1.52	-1.3	-1.7	-1.38	410.26	349.61	371.91	-278.86	-685.75	-57.83	-36.21	-26.9	-22.45	-0.32
Long-Term Debt/Total Assets (%)	2.43	1.92	1.38	0.75	0.53	27.22	26.23	24.14	27.92	26.4	30.17	28.98	40.12	43.32	2.92
Total Debt/Equity (%)	5.64	5.1	3.11	1.4	0.99	53.87	48.54	49.84	64.45	56.17	80.31	109.24	126.34	184.7	-120.85
Total Debt/Capital (%)	-1.84	-1.79	-1.58	-2.16	-1.87	411.88	351.01	379.96	-279.4	-686.98	-59.83	-51.33	-28.1	-22.65	-19.12
Total Debt/Total Assets (%)	2.43	2.26	1.68	0.95	0.72	27.32	26.34	24.66	27.97	26.45	31.21	41.09	41.92	43.71	175.9
CFO/Total Liabilities	21.21	-10.07	38.06	29.05	23.56	14.22	7.57	4.37	14.33	21.93	-26.22	-15.46	-13.59	-6.93	-5.25
CFO/CapEx	15.92	-2.03	11.46	3.84	2.68	0.15	5.45	0.11	6.76	4.45	-1.42	-13.9	-216.48	-153.85	-52.97
Altman's Z-Score	1.32	2.69	3.64	3.85	4.95	3.2	3.7	1.5	2.23	1.82	-2.4	-4.11	-10.72	-14.09	-21.09

Working Capital (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	10.55	13.64	12.96	12.44	11.78	12.75	15.47	12.42	8.8	8.99	8.46	7.24	6.94	7.68	7.55
Days Sales Outstanding	34.59	26.76	28.16	29.33	30.98	28.64	23.59	29.4	41.46	40.58	43.17	50.44	52.59	47.51	48.35
Inventory Turnover	1.7	1.6	1.99	2.34	2.83	3.04	2.94	2.72	2.78	2.94	1.29	1.24	1.73	1.94	1.06
Days Inventory Outstanding	215.13	228.57	183.14	156.21	129.06	120	124.34	134.39	131.45	124.32	284.02	293.51	211.31	188.32	345.19
Accounts Payable Turnover	1.09	4.74	2.8	2.11	3.41	4.25	5.49	4.89	3.49	2.22	0.82	1.83	2.41	2.24	1.52
Accounts Payable Turnover Days	335.98	77.03	130.2	172.82	107.1	85.94	66.48	74.71	104.68	164.67	447.82	199.52	151.16	162.91	240.52
Cash Conversion Cycle	-86.27	178.31	81.1	12.73	52.95	62.7	81.45	89.08	68.23	0.24	-120.63	144.43	112.73	72.93	153.01
Inventory to Cash Days	-180.54	-201.81	-154.97	-126.88	-98.08	-91.37	-100.75	-104.99	-89.99	-83.74	-240.85	-243.07	-158.71	-140.81	-296.84
Inventories	7	38	28	21	26	27	36	43	38	29	25	29	19	13	16
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	3	3	6	4
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	7	- -	- -	2
Finished Goods	7	38	28	21	26	27	36	43	38	29	10	19	15	7	9
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	951	1,046	930	981	1,174	1,682	1,807	851	987	732	97	33	25	16	19
- Cash & Cash Equivalents	47	35	58	42	48	182	153	159	307	294	62	71	46	38	30
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	8	8	6	5	4	291	293	331	335	344	250	260	191	173	191
Enterprise Value	687	813	640	753	905	1,665	1,746	1,023	1,015	631	221	222	171	151	180
Total Capital	-421	-432	-403	-249	-234	71	83	87	-120	-50	-417	-506	-679	-763	-998
Total Debt/Capital (%)	-1.84	-1.79	-1.58	-2.16	-1.87	411.88	351.01	379.96	-279.4	-686.98	-59.83	-51.33	-28.1	-22.65	-19.12
Total Debt / EV	0.01	0.01	0.01	0.01	- -	0.17	0.17	0.32	0.33	0.55	1.13	1.17	1.12	1.15	1.06
EV/Sales	12.56	4.26	2.19	2.46	2.69	4.15	3.54	1.97	1.72	1.34	1.15	1.45	1.32	1.27	1.53
EV/EBITDA	- -	- -	16.14	24.86	24.21	30.81	29.15	- -	7.92	6.01	- -	- -	- -	- -	21.38
EV/EBIT	- -	- -	18.26	29.39	29.79	36.53	38.89	- -	9.68	6.75	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	9.18	11.74	22.32	20.68	36.9	23.49	8.93	3.38	- -	- -	- -	4.25	13.87
EV/Free Cash Flow to Firm	- -	- -	8.48	9.68	16.39	2.95	32.11	3.23	7.92	2.86	- -	- -	- -	4.23	13.6
Diluted Market Cap	951	1,046	955	1,003	1,217	1,739	1,866	851	987	738	97	33	25	16	19
Diluted Enterprise Value	911	1,019	904	966	1,173	1,848	2,006	1,023	1,015	788	285	222	171	151	180
EV per Share	2,183.37	2,544.38	1,969.93	2,288.49	2,699.52	4,856.02	4,961.37	2,713.4	2,647.18	1,609.75	557.09	549.35	321.42	149.31	144.65
TTM Sales	55	191	292	306	336	401	493	520	588	471	192	153	129	119	118
TTM EBITDA	-78	-4	40	30	37	54	60	-6	128	105	-86	-46	-43	-9	8
TTM Operating Income	-81	-8	35	26	30	46	45	-27	105	93	-121	-87	-77	-42	-23
TTM Cash Flow to Firm	- -	-15	70	64	41	81	47	44	114	186	-106	-33	-13	36	13
TTM Free Cash Flow to Firm	- -	-6	76	78	55	564	54	317	128	220	-16	-28	-13	36	13

Multiples (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	23.16	-107.01	13.24	15.26	22.56	3.11	40.97	2.81	8.85	3.99	-2.57	-0.59	-0.62	-0.75	-1.37
EV/EBIT	- -	- -	18.26	29.39	29.79	36.53	38.89	- -	9.68	6.75	- -	- -	- -	- -	- -
Enterprise Value	687	813	640	753	905	1,665	1,746	1,023	1,015	631	221	222	171	151	180
Low Price	1,862.4	2,998.8	2,203.2	2,524.8	2,937.6	3,301.2	3,060	1,968	1,632	1,543.2	178.8	50.4	45	5.2	9
EV/Sales	12.56	4.26	2.19	2.46	2.69	4.15	3.54	1.97	1.72	1.34	1.15	1.45	1.32	1.27	1.53
EV/EBITDA	- -	- -	16.14	24.86	24.21	30.81	29.15	- -	7.92	6.01	- -	- -	- -	- -	21.38
Price/Earnings	- -	- -	30.38	6.33	71.41	95.17	163.38	- -	- -	21.75	- -	- -	- -	- -	- -
Price/Earnings Average	-10.55	-102.98	31.94	6.29	80.9	78.4	132.68	-34.68	-4.45	32.93	-1.37	-0.47	-0.46	-0.29	-0.07
Price/Earnings High	-13.16	-131.92	42.66	7.06	99.95	96.98	173.57	-55.79	-6.83	50.73	-3.06	-1.35	-0.88	-0.8	-0.12
Price/Earnings Low	-6.98	-81.44	23.4	5.36	59.87	64.06	97.38	-21.44	-2.81	17.95	-0.26	-0.2	-0.23	-0.08	-0.04
Price/Book Value	-2.22	-2.38	-2.27	-3.85	-4.93	-7.63	-8.63	-3.49	-2.17	-1.86	-0.15	-0.04	-0.03	-0.02	-0.02
Price/Book Value Average	-2.07	-2.75	-2.39	-3.83	-5.59	-6.29	-7.01	-4.92	-2.18	-2.82	-0.56	-0.06	-0.06	-0.02	-0.01
Price/Book Value High	-2.58	-3.53	-3.19	-4.3	-6.9	-7.78	-9.17	-7.92	-3.34	-4.34	-1.25	-0.18	-0.11	-0.06	-0.03
Price/Book Value Low	-1.37	-2.18	-1.75	-3.26	-4.13	-5.14	-5.14	-3.04	-1.37	-1.54	-0.11	-0.03	-0.03	-0.01	-0.01
Price/Tangible Book Value	7.91	8.05	4.73	2.6	2.78	-22.27	-157.55	-2.37	-5	-7.42	-1.06	-0.26	-0.14	-0.07	-0.1
Price/Tangible Book Value Average	7.37	9.33	4.98	2.59	3.15	-18.35	-127.95	-3.35	-5.02	-11.25	-4.09	-0.37	-0.26	-0.09	-0.09
Price/Tangible Book Value High	9.19	11.95	6.65	2.91	3.89	-22.69	-167.38	-5.38	-7.7	-17.32	-9.13	-1.04	-0.5	-0.25	-0.17
Price/Tangible Book Value Low	4.87	7.38	3.65	2.2	2.33	-14.99	-93.91	-2.07	-3.17	-6.13	-0.77	-0.16	-0.13	-0.02	-0.06
Price/Sales	17.39	5.47	3.18	3.21	3.49	4.19	3.67	1.64	1.68	1.55	0.5	0.22	0.2	0.13	0.16
Price/Sales Average	16.2	6.35	3.34	3.19	3.95	3.45	2.98	2.31	1.68	2.35	1.95	0.31	0.37	0.16	0.14
Price/Sales High	20.2	8.13	4.47	3.58	4.88	4.27	3.9	3.72	2.58	3.62	4.34	0.88	0.71	0.44	0.26
Price/Sales Low	10.71	5.02	2.45	2.71	2.93	2.82	2.19	1.43	1.06	1.28	0.37	0.13	0.19	0.04	0.1
Price/Cash Flow	24.61	-54.41	14.02	18.82	29.89	22.53	46.95	28.7	10.16	4.86	-0.76	-0.55	-0.61	-0.74	-1.34
Price/Cash Flow Average	22.92	-63.07	14.73	18.7	33.86	18.56	38.13	40.49	10.19	7.36	-2.92	-0.77	-1.16	-0.93	-1.22
Price/Cash Flow High	28.59	-80.8	19.68	21	41.83	22.96	49.88	65.13	15.63	11.33	-6.52	-2.2	-2.22	-2.51	-2.15
Price/Cash Flow Low	15.16	-49.88	10.79	15.93	25.06	15.16	27.98	25.03	6.44	4.01	-0.55	-0.33	-0.58	-0.25	-0.8
Price/Free Cash Flow Average	21.56	-124.04	13.92	15.17	25.56	2.56	33.27	3.96	8.88	6.05	-9.93	-0.83	-1.16	-0.93	-1.24
Price/Free Cash Flow High	26.9	-158.9	18.6	17.03	31.58	3.17	43.53	6.37	13.61	9.32	-22.14	-2.37	-2.23	-2.53	-2.19
Price/Free Cash Flow Low	14.26	-98.1	10.2	12.92	18.91	2.1	24.42	2.45	5.61	3.3	-1.88	-0.36	-0.58	-0.25	-0.81
EV/Sales Average	15.47	6.2	3.17	3.07	3.82	3.72	3.26	2.64	1.73	2.46	2.92	1.54	1.5	1.31	1.51
EV/Sales High	19.48	7.99	4.29	3.46	4.75	4.54	4.18	4.05	2.63	3.73	5.32	2.11	1.84	1.59	1.62
EV/Sales Low	9.99	4.88	2.27	2.6	2.8	3.09	2.47	1.76	1.11	1.39	1.34	1.37	1.31	1.19	1.46
EV/EBITDA Average	-10.78	-264.58	23.33	31	34.43	27.65	26.82	-236.72	7.95	11.05	-6.51	-5.17	-4.46	-16.77	21.18
EV/EBITDA High	-13.57	-340.63	31.61	34.96	42.81	33.72	34.37	-362.71	12.07	16.76	-11.84	-7.08	-5.47	-20.37	22.73
EV/EBITDA Low	-6.96	-207.99	16.75	26.23	25.17	22.96	20.31	-157.72	5.1	6.24	-2.99	-4.58	-3.9	-15.24	20.48
EV/EBIT Average	-10.41	-140.57	26.41	36.65	42.37	32.79	35.79	-50.14	9.71	12.4	-4.65	-2.71	-2.5	-3.68	-7.65
EV/EBIT High	-13.11	-180.98	35.78	41.33	52.68	39.99	45.86	-76.83	14.75	18.82	-8.46	-3.72	-3.07	-4.47	-8.21
EV/EBIT Low	-6.72	-110.51	18.96	31	30.98	27.22	27.1	-33.41	6.23	7	-2.14	-2.4	-2.19	-3.35	-7.4
Last Price	3,024	3,271.2	2,860.8	2,983.2	3,504	4,904.4	5,133.6	2,256	2,574	1,869.6	244.8	82.8	47.8	15.4	15.09
High Price	3,512.4	4,857.6	4,017.6	3,328.8	4,904.4	4,998	5,454	5,120.4	3,960	4,362	2,108.4	332.4	173.2	52	24.2
Enterprise Value Average	846	1,185	926	938	1,286	1,494	1,607	1,373	1,018	1,159	562	236	193	155	178
Enterprise Value High	1,065	1,526	1,254	1,058	1,600	1,823	2,059	2,104	1,546	1,759	1,023	323	237	188	191
Enterprise Value Low	546	932	664	794	941	1,241	1,216	915	654	655	258	209	169	141	172

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1
Revenue per Share	173.87	597.59	899.19	930.02	1,004.07	1,170.78	1,399.93	1,377.67	1,534.7	1,203.4	485.45	378.44	243.05	117.28	94.71
EBITDA per Share	-249.62	-14.01	122.09	92.04	111.51	157.63	170.22	-15.38	334.14	267.94	-218.07	-112.81	-81.62	-9.13	6.76
Operating Income per Share	-258.4	-26.37	107.86	77.86	90.62	132.92	127.56	-72.6	273.53	238.64	-305.3	-214.99	-145.56	-41.58	-18.73
Basic EPS, GAAP	-266.94	-36.82	94.17	471.25	49.07	51.53	31.42	-91.79	-580.12	85.98	-688.7	-246.4	-195.75	-65.2	-203.59
Basic EPS from Cont Ops	-266.94	-36.82	94.17	471.25	49.07	51.53	31.42	-94.4	-582.69	85.98	-688.7	-246.4	-195.75	-65.2	-203.59
Diluted EPS, GAAP	-266.94	-36.82	91.67	461.05	47.33	49.85	30.42	-91.79	-580.12	85.38	-688.7	-246.4	-195.75	-65.2	-203.59
Diluted EPS from Cont Ops	-266.94	-36.82	91.67	461.05	47.33	49.85	30.42	-94.4	-582.69	85.38	-688.7	-246.4	-195.75	-65.2	-203.59
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	122.86	-60.12	204.11	158.5	117.25	217.69	109.35	78.61	253.4	384.92	-323.37	-150.93	-77.86	-20.7	-11.26
Free Cash Flow per Basic Share	115.14	-89.66	186.3	117.21	73.48	-1,193.54	89.27	-646.65	215.9	298.35	-551.52	-161.79	-78.22	-20.83	-11.47
Cash & Equivalents per Share	865.27	750.97	910.48	711.09	817.53	897.06	1,003.94	420.35	801.06	1,137.34	317.5	176.57	85.93	37.13	24.14
Book Value per Share	-1,361.96	-1,376.76	-1,259.82	-773.92	-710.43	-642.63	-594.77	-646.74	-1,187.14	-1,005.22	-1,682.36	-1,896.08	-1,638.91	-926.06	-957.43
Tangible Book Value per Share	382.19	406.49	604.43	1,145.3	1,262.12	-220.23	-32.58	-950.87	-514.52	-251.81	-230.88	-319.21	-348.07	-209.16	-145.69

Acorda Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)